IGF2BP3 and urinary bladder carcinoma: Our results revealed an upregulation of IGF2BP3 in bladder cancer tissues and IGF2BP3 knockdown could reduce bladder cancer cell proliferation, prevent CDDP resistance, induce cell apoptosis, and inhibit bladder tumorigenesis in mice.